Skip to content

Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01985490
Enrollment
32
Registered
2013-11-15
Start date
2013-11-30
Completion date
2015-05-31
Last updated
2013-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epiretinal Membrane

Keywords

epiretinal membrane, foveal avascular zone, internal limiting membrane

Brief summary

Fovea is characterized by its vessel-free zone, called foveal avascular zone and it can be visualized by fluorescein angiography. Removal of epiretinal membrane and internal limiting membrane is frequently performed procedure and we suspected that these procedures may affect integrity of foveal avascular zone. The purpose of the present study is to evaluate the change of foveal avascular zone after removal of epiretinal membrane and internal limiting membrane

Interventions

PROCEDUREepiretinal membrane and internal limiting membrane removal

fluorescein angiography is performed before, 1 week, 3months and 6months after the epiretinal membrane and internal limiting membrane removal.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* epiretinal membrane

Exclusion criteria

* history of vitrectomy, intraocular surgery * any macular disease other than epiretinal membrane * media opacity obscuring the image of fluorescein angiography

Design outcomes

Primary

MeasureTime frameDescription
area of foveal avascular zonepostoperative 6 monthsthe change in area of foveal avascular zone at postoperative 6 months

Secondary

MeasureTime frame
change in visual acuitypostoperative 6 months
change in macular thicknessat 6 months
change in metamorphopsiapostoperative 6 months

Countries

South Korea

Contacts

Primary ContactSe Woong Kang, MD
swkang@skku.edu82-2-3410-3562

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026